Ikena Oncology, Inc. (IKNA) Misses Q2 EPS by 8c

Ikena Oncology, Inc. (NASDAQ: IKNA) reported Q2 EPS of ($0.57), $0.08 worse than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Ikena Oncology, Inc. (IKNA) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Vertiv to acquire microgrid firm UtilityInnovation Group for $1.45B
• BofA Securities Downgrades Amrize Ltd (AMRZ) to Underperform